Your browser doesn't support javascript.
loading
Meta-analysis of 16 studies of the association of alcohol with colorectal cancer.
McNabb, Sarah; Harrison, Tabitha A; Albanes, Demetrius; Berndt, Sonja I; Brenner, Hermann; Caan, Bette J; Campbell, Peter T; Cao, Yin; Chang-Claude, Jenny; Chan, Andrew; Chen, Zhengyi; English, Dallas R; Giles, Graham G; Giovannucci, Edward L; Goodman, Phyllis J; Hayes, Richard B; Hoffmeister, Michael; Jacobs, Eric J; Joshi, Amit D; Larsson, Susanna C; Le Marchand, Loïc; Li, Li; Lin, Yi; Männistö, Satu; Milne, Roger L; Nan, Hongmei; Newton, Christina C; Ogino, Shuji; Parfrey, Patrick S; Petersen, Paneen S; Potter, John D; Schoen, Robert E; Slattery, Martha L; Su, Yu-Ru; Tangen, Catherine M; Tucker, Thomas C; Weinstein, Stephanie J; White, Emily; Wolk, Alicja; Woods, Michael O; Phipps, Amanda I; Peters, Ulrike.
Affiliation
  • McNabb S; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Harrison TA; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA.
  • Albanes D; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Brenner H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
  • Caan BJ; Division of Clinical Epidemiology and Aging Research, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Campbell PT; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Cao Y; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Chang-Claude J; Division of Research, Kaiser Permanente Medical Research Program, Oakland, CA.
  • Chan A; Epidemiology Research Program, American Cancer Society, New York, NY.
  • Chen Z; Division of Public Health Sciences, Washington University in St Louis, St. Louis, MO.
  • English DR; Unit of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Giles GG; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA.
  • Giovannucci EL; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Goodman PJ; Center for Community Health Integration, Case Western Reserve University School of Medicine, Cleveland, OH.
  • Hayes RB; Centre for Epidemiology and Biostatistics, School of Population & Global Health, University of Melbourne, Melbourne, VIC, Australia.
  • Hoffmeister M; Cancer Epidemiology Center, The Cancer Council Victoria, Melbourne, VIC, Australia.
  • Jacobs EJ; Centre for Epidemiology and Biostatistics, School of Population & Global Health, University of Melbourne, Melbourne, VIC, Australia.
  • Joshi AD; Cancer Epidemiology Center, The Cancer Council Victoria, Melbourne, VIC, Australia.
  • Larsson SC; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Le Marchand L; Department of Epidemiology and Nutrition, Harvard School of Public Health, Boston, MA.
  • Li L; Department of Medicine, Harvard Medical School, Boston, MA.
  • Lin Y; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Männistö S; Division of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY.
  • Milne RL; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Nan H; Epidemiology Research Program, American Cancer Society, New York, NY.
  • Newton CC; Department of Epidemiology, Harvard School of Public Health, Boston, MA.
  • Ogino S; Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Parfrey PS; Institute of Environmental Medicine, Karolinska Institutet, Solna, Sweden.
  • Petersen PS; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI.
  • Potter JD; Department of Family Medicine, University of Virginia, Charlottesville, VA.
  • Schoen RE; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Slattery ML; Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
  • Su YR; Centre for Epidemiology and Biostatistics, School of Population & Global Health, University of Melbourne, Melbourne, VIC, Australia.
  • Tangen CM; Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.
  • Tucker TC; Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN.
  • Weinstein SJ; Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN.
  • White E; Behavioral and Epidemiology Research Group, American Cancer Society, New York, NY.
  • Wolk A; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Woods MO; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA.
  • Phipps AI; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Peters U; Broad Institute of MIT and Harvard, Cambridge, MA.
Int J Cancer ; 146(3): 861-873, 2020 02 01.
Article in En | MEDLINE | ID: mdl-31037736
ABSTRACT
Alcohol consumption is an established risk factor for colorectal cancer (CRC). However, while studies have consistently reported elevated risk of CRC among heavy drinkers, associations at moderate levels of alcohol consumption are less clear. We conducted a combined analysis of 16 studies of CRC to examine the shape of the alcohol-CRC association, investigate potential effect modifiers of the association, and examine differential effects of alcohol consumption by cancer anatomic site and stage. We collected information on alcohol consumption for 14,276 CRC cases and 15,802 controls from 5 case-control and 11 nested case-control studies of CRC. We compared adjusted logistic regression models with linear and restricted cubic splines to select a model that best fit the association between alcohol consumption and CRC. Study-specific results were pooled using fixed-effects meta-analysis. Compared to non-/occasional drinking (≤1 g/day), light/moderate drinking (up to 2 drinks/day) was associated with a decreased risk of CRC (odds ratio [OR] 0.92, 95% confidence interval [CI] 0.88-0.98, p = 0.005), heavy drinking (2-3 drinks/day) was not significantly associated with CRC risk (OR 1.11, 95% CI 0.99-1.24, p = 0.08) and very heavy drinking (more than 3 drinks/day) was associated with a significant increased risk (OR 1.25, 95% CI 1.11-1.40, p < 0.001). We observed no evidence of interactions with lifestyle risk factors or of differences by cancer site or stage. These results provide further evidence that there is a J-shaped association between alcohol consumption and CRC risk. This overall pattern was not significantly modified by other CRC risk factors and there was no effect heterogeneity by tumor site or stage.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Ethanol Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Ethanol Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2020 Type: Article